Alginate vs. Hyaluronic Acid as Carriers for Nucleus Pulposus Cells: A Study on Regenerative Outcomes in Disc Degeneration
Open Access
Abstract
Intervertebral disc degeneration is a leading cause of chronic low back pain, affecting millions globally. Regenerative medicine, particularly cell-based therapies, presents a promising therapeutic strategy. This study evaluates the comparative efficacy of two biomaterials—hyaluronic acid (HA) and alginate—as carriers for nucleus pulposus (NP) cell transplantation in a beagle model of induced disc degeneration. NP cells were isolated, cultured, and injected with either HA or alginate into degenerated discs, with saline and non-cell-loaded carriers used as controls. Disc height index, T2-weighted MRI, and histological analyses were conducted over a 12-week follow-up period to assess reparative outcomes. Imaging revealed that both carrier and cell-loaded treatments improved outcomes compared to degenerative controls, with cell-loaded carriers consistently outperforming carrier-only treated discs. Histological assessments supported these findings, showing trends toward extracellular matrix restoration in both treatment groups. While both biomaterials demonstrated reparative potential, HA showed greater consistency in supporting NP cells in promoting disc regeneration. These results underscore HA’s potential as a superior carrier for NP cell-based therapies in addressing disc degeneration.Keywords
Funding Information
- TUNZ Pharma Corporation (Osaka, Japan) (JP23ym0126124)
- Japanese Agency for Medical research and Development (AMED) (JP23ym0126124)
This publication has 118 references indexed in Scilit:
- Similarity and difference between aging and puncture‐induced intervertebral disc degenerationJournal of Orthopaedic Research, 2022
- Efficacy of hyaluronic acid on intervertebral disc inflammation: An in vitro study using notochordal cell lines and human disc cellsJournal of Orthopaedic Research, 2020
- Controversies in regenerative medicine: Should intervertebral disc degeneration be treated with mesenchymal stem cells?JOR SPINE, 2019
- Osteoarthritis and intervertebral disc degeneration: Quite different, quite similarJOR SPINE, 2018
- Mechanotransduction and cell biomechanics of the intervertebral discJOR SPINE, 2018
- Successful fishing for nucleus pulposus progenitor cells of the intervertebral disc across speciesJOR SPINE, 2018
- Discogenic cell transplantation directly from a cryopreserved state in an induced intervertebral disc degeneration canine modelJOR SPINE, 2018
- The chondrodystrophic dog: A clinically relevant intermediate‐sized animal model for the study of intervertebral disc‐associated spinal painJOR SPINE, 2018
- Clinically relevant hydrogel‐based on hyaluronic acid and platelet rich plasma as a carrier for mesenchymal stem cells: Rheological and biological characterizationJournal of Orthopaedic Research, 2017
- Microgel Microenvironment Primes Adipose‐Derived Stem Cells Towards an NP Cells‐Like PhenotypeAdvanced Healthcare Materials, 2014